Literature DB >> 1675994

Clonidine causes antidepressant-like effects in rats by activating alpha 2-adrenoceptors outside the locus coeruleus.

L Cervo1, R Samanin.   

Abstract

Clonidine, 0.05, 0.1 and 0.5 mg/kg administered i.p. as a three-injection course but not as single doses, significantly reduced the immobility of rats in the forced swimming test. Doses of 0.1 and 0.5, administered the same way, significantly reduced activity in an open field. The effect of 0.05 and 0.5 mg/kg clonidine on immobility was prevented by 1 mg/kg idazoxan, an alpha 2-adrenoceptor antagonist, but not by 3 mg/kg prazosin, which blocks alpha 1-adrenoceptors. An infusion of 6 micrograms/microliters 6-hydroxydopamine in the locus coeruleus, which markedly depleted noradrenaline in terminal regions, did not modify the effect of 0.05 and 0.5 mg/kg clonidine on immobility. Chronic treatment with 5 mg/kg i.p. desipramine or 0.1 mg/kg i.p. clonidine, twice daily for 15 days, did not modify the effect of a three-injection course with 0.1 mg/kg clonidine. It is suggested that clonidine exerts antidepressant-like effects on rats in the forced swimming test by acting on central alpha 2-adrenoceptors outside the locus coeruleus and presumably postsynaptically to noradrenaline-containing neurons. No tolerance or sensitization of the clonidine effect was found after chronic treatment with desipramine or clonidine. These findings are of significance for the effects of clonidine in subgroups of depressed patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675994     DOI: 10.1016/0014-2999(91)90144-f

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

Review 1.  The role of the central noradrenergic system in behavioral inhibition.

Authors:  Eric A Stone; Yan Lin; Yasmeen Sarfraz; David Quartermain
Journal:  Brain Res Rev       Date:  2011-03-05

2.  Noradrenergic antidepressant responses to desipramine in vivo are reciprocally regulated by arrestin3 and spinophilin.

Authors:  Christopher Cottingham; Xiaohua Li; Qin Wang
Journal:  Neuropharmacology       Date:  2012-02-19       Impact factor: 5.250

3.  Genetic differences in the synthesis and reception of noradrenaline in the mouse brain and behavior in a novel environment.

Authors:  N N Dyaglo; G T Shishkina
Journal:  Neurosci Behav Physiol       Date:  2000 May-Jun

Review 4.  α2 adrenergic receptor dysregulation in depressive disorders: implications for the neurobiology of depression and antidepressant therapy.

Authors:  Christopher Cottingham; Qin Wang
Journal:  Neurosci Biobehav Rev       Date:  2012-08-13       Impact factor: 8.989

Review 5.  Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer.

Authors:  Kedar S Prabhavalkar; Nimmy B Poovanpallil; Lokesh K Bhatt
Journal:  Front Pharmacol       Date:  2015-10-23       Impact factor: 5.810

Review 6.  Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia-New Developments and Future Perspective.

Authors:  Madeleine Monique Uys; Mohammed Shahid; Brian Herbert Harvey
Journal:  Front Psychiatry       Date:  2017-08-14       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.